TRV GP Iv, LLC, 10% Owner at Tango Therapeutics, Inc. (TNGX), sold 67,400 shares at $10.53 ($710K) on 2024-09-13, disclosed to the SEC on 2024-09-17.
Open-market sale of $710k TNGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| TNGX | SELL | 2025-09-17 | $5.1M | — | Filing → |
| TNGX | SELL | 2025-09-09 | $5.7M | — | Filing → |
| TNGX | SELL | 2024-09-09 | $867K | — | Filing → |